Future Family, Inc. is a subscription-based fertility service founded in 2016 and headquartered in San Francisco, California. The company provides comprehensive plans that cover all healthcare costs related to fertility, including in vitro fertilization (IVF) and egg freezing. Clients benefit from personalized fertility planning, clinic matching, and dedicated nurse concierge support. Future Family emphasizes accessibility with 24/7 access to a care team and offers a digital health platform to facilitate communication and care management. Their services also encompass clinic visits, medical procedures, laboratory work, and medication delivery, thereby creating a streamlined and stress-free experience for individuals and couples seeking fertility solutions.
PayGround, Inc. specializes in developing billing and payment software solutions tailored for the healthcare industry. Founded in 2018 and headquartered in Chandler, Arizona, the company offers a cloud-based financial platform that simplifies payment processes for healthcare providers and patients alike. Its services enable healthcare businesses to efficiently manage accounts receivable by sending digital payment requests through various channels, including email, text, and traditional mail. Patients benefit from a user-friendly experience, allowing them to view and settle billing records quickly, and even consolidate payments for multiple healthcare services into a single account. PayGround distinguishes itself by focusing on independent healthcare practices and integrating seamlessly with existing billing systems, facilitating a swift implementation process. The company's commitment to enhancing the billing experience helps reduce costs and streamline operations for healthcare providers.
Brightside Health, Inc. is a mental health care company that specializes in providing treatment for anxiety and depression through a mobile application. Founded in 2017 and headquartered in San Francisco, California, Brightside Health enables users to access personalized, expert care from the comfort of their homes. The platform offers various services, including depression evaluation, treatment monitoring, lifestyle tools, and therapy referrals, ensuring a comprehensive approach to mental well-being. Additionally, it facilitates communication between clients and healthcare providers for consultations and assessments. The company's mission is to empower individuals to lead healthy, productive lives by making high-quality mental health care accessible and affordable.
Day Zero Diagnostics (DZD) is developing a new class of diagnostic that enables a physician to switch from broad spectrum antibiotic therapy to a targeted antibiotic in 5 hours rather than the 2-5 days that it typically takes today. Unlike other molecular diagnostics that can only detect a handful of specific targets, DZD uses the entire genomic sequence and our proprietary Keynome™ algorithm to identify a comprehensive range of bacterial pathogens and their resistance characteristics within hours.
monogoto Programmable Cellular is an Infrastructure as a Service (IaaS) enabling Enterprises, MNO and MVNO to launch many cellular use cases, from IoT Connectivity to Travel SIM, Digital Wallet and much more. In addition, monogoto's IaaS can solve specific operators needs, such as Global Roaming, IMSI Donations, HLR Proxy, Revenue Assurance and Private LTE. They are the first company to expose true Self-Service via a Console, APIs and Native Mobile App for all network components, including: SIM Card, GGSN, HLR, HSS, SMSC and MQTT.
TailorMed Medical Ltd. is a health technology company that specializes in financial navigation systems designed to assist patients and healthcare providers in managing medical expenses. Founded in 2017 and based in Tel Aviv, Israel, TailorMed offers a comprehensive platform that automates financial processes, identifies patients at financial risk, and connects them with tailored funding opportunities. Its key products include TailorMed Financial Navigation, which streamlines financial operations for healthcare centers; TailorMed Financial Insights, a reporting dashboard that tracks key performance indicators; and TailorMed Pharmacy, which simplifies the ordering and billing of medications based on individual treatment plans. By leveraging advanced algorithms and a robust data set, TailorMed aims to reduce patient financial toxicity and improve efficiencies throughout the treatment lifecycle.
Grin is a digital orthodontic platform that connects patients with local orthodontists through a user-friendly app, facilitating teeth straightening for a diverse range of needs. Founded in 2019 and based in Oradell, New Jersey, Grin aims to provide accessible and high-quality orthodontic care by integrating modern technology with professional expertise. The platform allows for remote monitoring and virtual check-ins, enabling orthodontists to oversee treatment while minimizing in-office visits. This innovative approach not only enhances patient convenience but also improves operational efficiency for orthodontic practices. Grin's commitment to responsible care ensures that patients receive tailored treatment plans, resulting in effective and aesthetically pleasing outcomes.
EyeYon Medical Ltd. is an Israeli company specializing in the development of medical devices for the treatment of corneal edema. Founded by a team of experienced professionals in ophthalmology and business, the company is based in Jerusalem and operates within the Van Leer Technology Incubator. Its key products include Hyper-CL, a hyperosmotic contact lens that utilizes osmosis to extract fluids from corneal edema, thereby improving vision and alleviating pain. Additionally, EyeYon Medical offers DSPEK, an artificial endothelial layer designed to replace damaged endothelial tissue, which is crucial in cases of corneal edema. The company's innovative solutions are non-invasive, comfortable, and facilitate effective eye care for patients dealing with both acute and chronic ocular conditions.
BurnAlong, Inc. is a fitness and wellness platform that provides personalized online classes and social motivation to help individuals achieve their health goals. Founded in 2016 and based in Pikesville, Maryland, the company connects users with fitness instructors through video feeds, allowing them to work out together regardless of location. The platform serves a diverse clientele, including corporate employers, municipalities, insurers, brokers, individuals, and senior citizens. By leveraging machine learning, BurnAlong tailors class recommendations to suit various preferences, ranging from high-intensity workouts to meditation. This approach not only enhances individual wellness but also helps companies foster strong workplace cultures, enhancing employee retention and attraction.
PayGround, Inc. specializes in developing billing and payment software solutions tailored for the healthcare industry. Founded in 2018 and headquartered in Chandler, Arizona, the company offers a cloud-based financial platform that simplifies payment processes for healthcare providers and patients alike. Its services enable healthcare businesses to efficiently manage accounts receivable by sending digital payment requests through various channels, including email, text, and traditional mail. Patients benefit from a user-friendly experience, allowing them to view and settle billing records quickly, and even consolidate payments for multiple healthcare services into a single account. PayGround distinguishes itself by focusing on independent healthcare practices and integrating seamlessly with existing billing systems, facilitating a swift implementation process. The company's commitment to enhancing the billing experience helps reduce costs and streamline operations for healthcare providers.
MediSafe Project LTD. provides MediSafe, a cloud-synced mobile medication management solution that helps families in preventing emergencies caused by over-or under-dosing medications. It offers patient compliance and businesses solutions. The company was founded in 2012 and is based in Haifa, Israel.
Genoox, Ltd. is a company that develops a cloud-based big data platform designed for storing and managing genomic data. Founded in 2014 by Amir Trabelsi and Moshe Einhorn, the company is headquartered in Palo Alto, California. The platform enables medical professionals to deliver genetic diagnostics and personalized treatments by leveraging artificial intelligence and machine learning algorithms. These technologies help analyze rare genetic mutations and assess their potential role in various conditions, thereby improving the efficiency and accuracy of genetic screening processes. By streamlining the management of genomic data, Genoox enhances patient outcomes in clinical settings.
V-Wave Ltd. is a medical technology company based in Caesarea, Israel, with additional offices in the United States. Founded in 2009, it specializes in the development of percutaneous implantable therapeutic devices aimed at treating chronic heart failure (HF) patients, which is a major cause of morbidity and mortality worldwide. The company has created the V-Wave Shunt, a biocompatible inter-atrial unidirectional implant designed for patients with both preserved and reduced ejection fractions, addressing the needs of those who experience disabling symptoms despite optimal medical therapy. V-Wave's innovative approach focuses on relieving symptoms, reducing hospitalizations, enhancing exercise capacity, and improving overall quality of life for HF patients. The organization is backed by a team of experienced engineers and medical scientists who have a proven track record in developing and bringing various implantable cardiovascular devices to market.
BioProtect Ltd. is an international medical device startup focused on developing and commercializing biodegradable balloon spacers designed to protect normal tissue during cancer radiation therapy. The company's flagship product, the ProSpace balloon spacer, has demonstrated superior efficacy and safety in safeguarding the rectum during radiation treatment for prostate cancer. This innovative technology significantly reduces the risk of serious and chronic side effects associated with radiation, while enhancing tumor control. Founded in 2004 and headquartered in Israel, BioProtect also operates subsidiaries in Germany and the United States, aiming to address unmet clinical needs in the growing radiotherapy spacers market with its platform of biodegradable implantable balloons.
TuneFork is audio personalization technology software that delivers an optimal hearing experience anywhere you go, bringing out the very best from your mobile sound system. Hearing is an individual experience. Each of us has unique hearing “earprints”. This is why no one sound system is perfect for everyone. When you listen to unbalanced audio, you will always miss something. In some cases, you may even cause damage to your hearing. TuneFork guides you through a simple test which characterizes your hearing, creating a personal Audio Profile. Because our self-test is clinically accurate, it provides the best results possible, truly the Gold Standard in Audio experience. We use the test results to tailor a precise audio filter for each and every user, creating the perfect match between your sound system and your hearing. TuneFork can be integrated into any operating or network and optimize all audio content: *Phone calls *Music *Video *Voice messages *Rings & Alerts. With the spread of IoT more and more "smart" devices can carry TuneFork's advanced audio technology – smart TVs, smart cars, other smart devices, but above all: smartphones. Smartphone sales stood at 1.5 billion units in 2016. Their use extends far beyond two-way communication and includes music, video viewing, social networking and gaming. Any user can benefit from using TuneFork. For some it will break barriers created by hearing impairment, while for others it will deliver an improved audio experience from their device. Comparative Advantage A software only solution The most accurate self-test results Product proven by clinical tests in laboratory conditions 2 Patent pending
Lynx.MD Ltd is a company that specializes in federated learning software solutions aimed at making medical data accessible for data science and artificial intelligence applications. Founded in 2017 and headquartered in Tel Aviv, Israel, with an additional office in California, Lynx.MD offers a cloud platform that allows hospitals and medical organizations to securely access and share healthcare data. This platform fosters the development of AI-driven digital health applications designed to enhance patient care and reduce costs. By addressing the issue of data silos and promoting interoperability, Lynx.MD facilitates secure collaborations for clinical and operational research while ensuring patient privacy, ultimately improving healthcare delivery and driving innovation in the medical field.
Cala Health, Inc. is a bioelectronic medicine company focused on developing innovative therapies for chronic diseases. Based in Burlingame, California, the company specializes in wearable neuromodulation devices that utilize advancements in neuroscience and technology to provide individualized peripheral nerve stimulation. Its flagship product, Cala Trio, is a non-invasive therapy designed to offer relief from hand tremors in adults with essential tremor, a condition affecting millions. In addition to its current offerings, Cala Health is actively developing new therapeutic solutions in the fields of neurology, cardiology, and psychiatry, aiming to enhance the standard of care for patients with chronic conditions. Founded in 2013, the company has garnered support from prominent investors in both the healthcare and technology sectors.
TailorMed Medical Ltd. is a health technology company that specializes in financial navigation systems designed to assist patients and healthcare providers in managing medical expenses. Founded in 2017 and based in Tel Aviv, Israel, TailorMed offers a comprehensive platform that automates financial processes, identifies patients at financial risk, and connects them with tailored funding opportunities. Its key products include TailorMed Financial Navigation, which streamlines financial operations for healthcare centers; TailorMed Financial Insights, a reporting dashboard that tracks key performance indicators; and TailorMed Pharmacy, which simplifies the ordering and billing of medications based on individual treatment plans. By leveraging advanced algorithms and a robust data set, TailorMed aims to reduce patient financial toxicity and improve efficiencies throughout the treatment lifecycle.
Day Zero Diagnostics (DZD) is developing a new class of diagnostic that enables a physician to switch from broad spectrum antibiotic therapy to a targeted antibiotic in 5 hours rather than the 2-5 days that it typically takes today. Unlike other molecular diagnostics that can only detect a handful of specific targets, DZD uses the entire genomic sequence and our proprietary Keynome™ algorithm to identify a comprehensive range of bacterial pathogens and their resistance characteristics within hours.
Lynx.MD Ltd is a company that specializes in federated learning software solutions aimed at making medical data accessible for data science and artificial intelligence applications. Founded in 2017 and headquartered in Tel Aviv, Israel, with an additional office in California, Lynx.MD offers a cloud platform that allows hospitals and medical organizations to securely access and share healthcare data. This platform fosters the development of AI-driven digital health applications designed to enhance patient care and reduce costs. By addressing the issue of data silos and promoting interoperability, Lynx.MD facilitates secure collaborations for clinical and operational research while ensuring patient privacy, ultimately improving healthcare delivery and driving innovation in the medical field.
Genoox, Ltd. is a company that develops a cloud-based big data platform designed for storing and managing genomic data. Founded in 2014 by Amir Trabelsi and Moshe Einhorn, the company is headquartered in Palo Alto, California. The platform enables medical professionals to deliver genetic diagnostics and personalized treatments by leveraging artificial intelligence and machine learning algorithms. These technologies help analyze rare genetic mutations and assess their potential role in various conditions, thereby improving the efficiency and accuracy of genetic screening processes. By streamlining the management of genomic data, Genoox enhances patient outcomes in clinical settings.
V-Wave Ltd. is a medical technology company based in Caesarea, Israel, with additional offices in the United States. Founded in 2009, it specializes in the development of percutaneous implantable therapeutic devices aimed at treating chronic heart failure (HF) patients, which is a major cause of morbidity and mortality worldwide. The company has created the V-Wave Shunt, a biocompatible inter-atrial unidirectional implant designed for patients with both preserved and reduced ejection fractions, addressing the needs of those who experience disabling symptoms despite optimal medical therapy. V-Wave's innovative approach focuses on relieving symptoms, reducing hospitalizations, enhancing exercise capacity, and improving overall quality of life for HF patients. The organization is backed by a team of experienced engineers and medical scientists who have a proven track record in developing and bringing various implantable cardiovascular devices to market.
Vi delivers on-demand cardio audio workouts that are fun, effective, and adapt to you in real-time while anyone works out. Vi's mission is to democratize personal health & fitness through AI and voice
CathWorks Ltd. is a medical technology company based in Kfar-Saba, Israel, with an additional office in the United States. Founded in 2013, CathWorks specializes in developing advanced medical devices for the interventional cardiology market. The company's innovative technology leverages computational science and automatic multi-layered algorithms to enhance the utility of coronary angiography data, transforming visual assessments into objective decision-making tools for physicians. Its flagship product, CathWorks FFRangio, is a non-invasive device that provides objective multi-vessel physiological measurements, aimed at optimizing and confirming intra-procedural decisions for percutaneous coronary interventions (PCI). CathWorks is privately held and benefits from strong partnerships and support from leading venture capital firms in the medical devices sector.
Colospan Ltd is a clinical-stage medical device company based in Kfar Saba, Israel, established in 2010. It specializes in developing innovative technology aimed at improving outcomes in colorectal surgeries. The company has created a proprietary, single-use intraluminal bypass device designed to minimize the risk of anastomotic leaks following intestinal surgery, particularly in patients with severe inflammatory bowel diseases or colorectal cancer. This device helps reduce contact between fecal matter and the anastomotic site, thereby decreasing the likelihood of complications that could lead to prolonged hospitalization or the need for additional surgeries. By offering a temporary alternative to diverting colostomies, Colospan's products aim to enhance patient recovery while maintaining overall well-being and safety during the post-operative period.
ZingBox Inc. is a company specializing in Internet of Things (IoT) security solutions, primarily focusing on the healthcare and manufacturing sectors. Founded in 2014 and headquartered in Mountain View, California, ZingBox develops a real-time security platform designed to discover and protect connected devices from both cyber and insider threats. The company has formed a strategic partnership with First Health Advisory Solutions to enhance its offerings. ZingBox operates as a subsidiary of Palo Alto Networks, Inc., reinforcing its commitment to providing robust security measures for IoT infrastructures.
EyeYon Medical Ltd. is an Israeli company specializing in the development of medical devices for the treatment of corneal edema. Founded by a team of experienced professionals in ophthalmology and business, the company is based in Jerusalem and operates within the Van Leer Technology Incubator. Its key products include Hyper-CL, a hyperosmotic contact lens that utilizes osmosis to extract fluids from corneal edema, thereby improving vision and alleviating pain. Additionally, EyeYon Medical offers DSPEK, an artificial endothelial layer designed to replace damaged endothelial tissue, which is crucial in cases of corneal edema. The company's innovative solutions are non-invasive, comfortable, and facilitate effective eye care for patients dealing with both acute and chronic ocular conditions.
MediSafe Project LTD. provides MediSafe, a cloud-synced mobile medication management solution that helps families in preventing emergencies caused by over-or under-dosing medications. It offers patient compliance and businesses solutions. The company was founded in 2012 and is based in Haifa, Israel.
OrthoSpace Ltd. is a company based in Caesarea, Israel, that specializes in the development and commercialization of innovative orthopedic solutions. Founded in 2009, the company focuses on biodegradable balloon systems designed for the treatment of rotator cuff syndrome in Europe. Its flagship product, InSpace™, is a simple-to-implant device that mimics the function of the original bursa, providing a spacer between the acromion and the humeral head. This design alleviates pain and enhances the range of motion for patients suffering from rotator cuff injuries, while also facilitating smoother joint movement. InSpace™ has received the CE mark, allowing it to be marketed in Europe, and is part of OrthoSpace's commitment to creating effective orthopedic solutions that preserve bone and joint structures. As of March 2019, OrthoSpace operates as a subsidiary of Stryker Corporation.
Vi delivers on-demand cardio audio workouts that are fun, effective, and adapt to you in real-time while anyone works out. Vi's mission is to democratize personal health & fitness through AI and voice
V-Wave Ltd. is a medical technology company based in Caesarea, Israel, with additional offices in the United States. Founded in 2009, it specializes in the development of percutaneous implantable therapeutic devices aimed at treating chronic heart failure (HF) patients, which is a major cause of morbidity and mortality worldwide. The company has created the V-Wave Shunt, a biocompatible inter-atrial unidirectional implant designed for patients with both preserved and reduced ejection fractions, addressing the needs of those who experience disabling symptoms despite optimal medical therapy. V-Wave's innovative approach focuses on relieving symptoms, reducing hospitalizations, enhancing exercise capacity, and improving overall quality of life for HF patients. The organization is backed by a team of experienced engineers and medical scientists who have a proven track record in developing and bringing various implantable cardiovascular devices to market.
6over6 is a digital healthcare company that has created a platform allowing users to conduct their own eye vision tests using their smartphones. The platform integrates essential optometric tools to accurately measure the refractive error of the eye, facilitating the prescription of eyeglasses and contact lenses. By utilizing software to retrieve optical parameters from existing eyewear, 6over6 aims to make vision care more accessible. Their product, GlassesOn, is registered as a Class 1 Exempt Medical Device with the FDA. However, it is important to note that GlassesOn does not offer medical advice and is not a substitute for a comprehensive eye health examination.
MST Medical Surgery Technologies Ltd. develops innovative image analysis software aimed at enhancing surgical procedures in the healthcare sector. Founded in 2005 by entrepreneurs Ziv Tamir and Moti Sholev, the company is headquartered in Tel Aviv, Israel, with an additional office in Apollo Beach, Florida. MST's flagship product, AutoLap, is a robotic image-guided laparoscope positioning system that utilizes advanced image analysis technology to provide surgeons with real-time control during operations, ensuring an optimal field of view. Additionally, the company offers Surgical Training Analytics (STA), a tool designed to capture and analyze images from actual surgeries performed by trainee surgeons. By leveraging artificial intelligence, machine learning, and data analytics, MST aims to empower and automate the surgical environment, thereby improving outcomes for surgeons, healthcare providers, and patients alike.
MST Medical Surgery Technologies Ltd. develops innovative image analysis software aimed at enhancing surgical procedures in the healthcare sector. Founded in 2005 by entrepreneurs Ziv Tamir and Moti Sholev, the company is headquartered in Tel Aviv, Israel, with an additional office in Apollo Beach, Florida. MST's flagship product, AutoLap, is a robotic image-guided laparoscope positioning system that utilizes advanced image analysis technology to provide surgeons with real-time control during operations, ensuring an optimal field of view. Additionally, the company offers Surgical Training Analytics (STA), a tool designed to capture and analyze images from actual surgeries performed by trainee surgeons. By leveraging artificial intelligence, machine learning, and data analytics, MST aims to empower and automate the surgical environment, thereby improving outcomes for surgeons, healthcare providers, and patients alike.
OrthoSpace Ltd. is a company based in Caesarea, Israel, that specializes in the development and commercialization of innovative orthopedic solutions. Founded in 2009, the company focuses on biodegradable balloon systems designed for the treatment of rotator cuff syndrome in Europe. Its flagship product, InSpace™, is a simple-to-implant device that mimics the function of the original bursa, providing a spacer between the acromion and the humeral head. This design alleviates pain and enhances the range of motion for patients suffering from rotator cuff injuries, while also facilitating smoother joint movement. InSpace™ has received the CE mark, allowing it to be marketed in Europe, and is part of OrthoSpace's commitment to creating effective orthopedic solutions that preserve bone and joint structures. As of March 2019, OrthoSpace operates as a subsidiary of Stryker Corporation.
Angioslide, Ltd. is a medical device company established in 2005 and headquartered in Natanya, Israel, with additional subsidiaries in Karlsruhe, Germany, and Edina, Minnesota. The company specializes in developing innovative angioplasty products, notably the Angioslide eXtra balloon catheter, which serves both as a stand-alone balloon for angioplasty and as a device for debris removal. Its proprietary Embolic Capture Angioplasty™ technology allows physicians to capture and eliminate embolic particles, chronic thrombus, and atherosclerotic plaque debris during angioplasty procedures. Angioslide focuses on addressing the needs of various markets, including peripheral artery, lower limb artery, carotid, and coronary artery diseases.
EyeYon Medical Ltd. is an Israeli company specializing in the development of medical devices for the treatment of corneal edema. Founded by a team of experienced professionals in ophthalmology and business, the company is based in Jerusalem and operates within the Van Leer Technology Incubator. Its key products include Hyper-CL, a hyperosmotic contact lens that utilizes osmosis to extract fluids from corneal edema, thereby improving vision and alleviating pain. Additionally, EyeYon Medical offers DSPEK, an artificial endothelial layer designed to replace damaged endothelial tissue, which is crucial in cases of corneal edema. The company's innovative solutions are non-invasive, comfortable, and facilitate effective eye care for patients dealing with both acute and chronic ocular conditions.
MediSafe Project LTD. provides MediSafe, a cloud-synced mobile medication management solution that helps families in preventing emergencies caused by over-or under-dosing medications. It offers patient compliance and businesses solutions. The company was founded in 2012 and is based in Haifa, Israel.
BioGaming offers an innovative virtual reality platform aimed at enhancing rehabilitation outcomes for patients undergoing physiotherapy. The company utilizes home-based gaming consoles and advanced 3D sensing technologies to monitor patient performance. By incorporating clinically developed exercise routines, BioGaming creates an engaging virtual environment where rehabilitation exercises are gamified, making them more enjoyable for users. The platform employs motion analysis systems and machine learning algorithms to generate detailed quantitative and qualitative reports on patient progress, allowing physical therapists to remotely prescribe and adjust exercise programs effectively. This dual approach benefits both patients, who experience a more engaging rehabilitation process, and therapists, who gain valuable insights into their patients' performance.
Cardiva Medical, Inc. is a medical device company that specializes in vascular access management products aimed at facilitating the body's natural healing process after percutaneous catheterization procedures. Its product lineup includes VASCADE VCS, a bioabsorbable femoral access closure system that promotes rapid hemostasis and reduces complications. Additionally, Cardiva offers the Catalyst manual compression assistance device, which supports temporary hemostasis and improves coagulation for patients needing manual compression. The company also manufactures VASCADE MVP, a vascular closure system for multi-site venous closure during electrophysiology procedures such as cardiac ablation. Founded in 2002 and headquartered in Santa Clara, California, Cardiva Medical serves physicians and cardiac centers across the United States.
Apica Cardiovascular is a pre-revenue medical device company focused on a novel technology for accessing and closing the heart's apex and the peripheral vascular system. This technology facilitates the delivery of large therapeutic devices, such as transcatheter heart valves and devices used in aortic aneurysm repair and left ventricular assist device implantation, through minimally invasive surgical or percutaneous approaches. By standardizing access and closure techniques, the technology aims to minimize blood loss during procedures on a beating heart. Having successfully demonstrated its initial concept in animal and cadaver models, Apica Cardiovascular is now preparing to advance to initial clinical trials.
MediSafe Project LTD. provides MediSafe, a cloud-synced mobile medication management solution that helps families in preventing emergencies caused by over-or under-dosing medications. It offers patient compliance and businesses solutions. The company was founded in 2012 and is based in Haifa, Israel.
Angioslide, Ltd. is a medical device company established in 2005 and headquartered in Natanya, Israel, with additional subsidiaries in Karlsruhe, Germany, and Edina, Minnesota. The company specializes in developing innovative angioplasty products, notably the Angioslide eXtra balloon catheter, which serves both as a stand-alone balloon for angioplasty and as a device for debris removal. Its proprietary Embolic Capture Angioplasty™ technology allows physicians to capture and eliminate embolic particles, chronic thrombus, and atherosclerotic plaque debris during angioplasty procedures. Angioslide focuses on addressing the needs of various markets, including peripheral artery, lower limb artery, carotid, and coronary artery diseases.
Cardiva Medical, Inc. is a medical device company that specializes in vascular access management products aimed at facilitating the body's natural healing process after percutaneous catheterization procedures. Its product lineup includes VASCADE VCS, a bioabsorbable femoral access closure system that promotes rapid hemostasis and reduces complications. Additionally, Cardiva offers the Catalyst manual compression assistance device, which supports temporary hemostasis and improves coagulation for patients needing manual compression. The company also manufactures VASCADE MVP, a vascular closure system for multi-site venous closure during electrophysiology procedures such as cardiac ablation. Founded in 2002 and headquartered in Santa Clara, California, Cardiva Medical serves physicians and cardiac centers across the United States.